293 related articles for article (PubMed ID: 25089127)
1. Pediatric Graves' disease: management in the post-propylthiouracil Era.
Rivkees SA
Int J Pediatr Endocrinol; 2014; 2014(1):10. PubMed ID: 25089127
[TBL] [Abstract][Full Text] [Related]
2. Controversies in the management of Graves' disease in children.
Rivkees SA
J Endocrinol Invest; 2016 Nov; 39(11):1247-1257. PubMed ID: 27153850
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Graves' disease: controversies in management.
Rivkees SA
Horm Res Paediatr; 2010; 74(5):305-11. PubMed ID: 20924158
[TBL] [Abstract][Full Text] [Related]
4. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.
Kahaly GJ; Bartalena L; Hegedüs L; Leenhardt L; Poppe K; Pearce SH
Eur Thyroid J; 2018 Aug; 7(4):167-186. PubMed ID: 30283735
[TBL] [Abstract][Full Text] [Related]
5. Approach to the Patient: Management and the Long-term Consequences of Graves' Disease in Children.
Rivkees SA
J Clin Endocrinol Metab; 2022 Nov; 107(12):3408-3417. PubMed ID: 36184734
[TBL] [Abstract][Full Text] [Related]
6. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Plasma Exchange as a Bridging Therapy for the Definitive Treatment of a Patient with Graves' Disease and Methimazole-Induced Liver Injury.
Purnamasari D; Wildan A; Kurniawan J; Mulansari NA; Karim B; Danil Yulian E
Int J Endocrinol Metab; 2023 Jul; 21(3):e136608. PubMed ID: 38028251
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
9. Propylthiouracil-induced agranulocytosis as a rare complication of antithyroid drugs in a patient with Graves' disease.
Rabelo PN; Rabelo PN; Paula AF; Conceição SAD; Viggiano DPPO; Antunes DE; Jatene EM; Paula SLFM; Dias ML; Reis MAL
Rev Assoc Med Bras (1992); 2019 Jul; 65(6):755-760. PubMed ID: 31340298
[TBL] [Abstract][Full Text] [Related]
10. 2022 European Thyroid Association Guideline for the management of pediatric Graves' disease.
Mooij CF; Cheetham TD; Verburg FA; Eckstein A; Pearce SH; Léger J; van Trotsenburg ASP
Eur Thyroid J; 2022 Jan; 11(1):. PubMed ID: 34981748
[TBL] [Abstract][Full Text] [Related]
11. Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institution.
Ohye H; Minagawa A; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Suzuki M; Yoshihara A; Ito K; Ito K
Thyroid; 2014 Feb; 24(2):200-7. PubMed ID: 23926918
[TBL] [Abstract][Full Text] [Related]
12. SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Yu W; Wu N; Li L; Wang J; OuYang H; Shen H
Endocr Pract; 2020 Feb; 26(2):207-217. PubMed ID: 31652102
[No Abstract] [Full Text] [Related]
13. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
14. Anti-thyroid drugs in pediatric Graves' disease.
John M; Sundrarajan R; Gomadam SS
Indian J Endocrinol Metab; 2015; 19(3):340-6. PubMed ID: 25932387
[TBL] [Abstract][Full Text] [Related]
15. A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA.
Beshyah SA; Khalil AB; Sherif IH; Benbarka MM; Raza SA; Hussein W; Alzahrani AS; Chadli A
Endocr Pract; 2017 Mar; 23(3):299-308. PubMed ID: 27967219
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
[TBL] [Abstract][Full Text] [Related]
17. "Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients.
Vigone MC; Peroni E; Di Frenna M; Mora S; Barera G; Weber G
J Endocrinol Invest; 2020 May; 43(5):595-600. PubMed ID: 31713721
[TBL] [Abstract][Full Text] [Related]
18. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity and cutaneous reactions after antithyroid drug administration.
Otsuka F; Noh JY; Chino T; Shimizu T; Mukasa K; Ito K; Ito K; Taniyama M
Clin Endocrinol (Oxf); 2012 Aug; 77(2):310-5. PubMed ID: 22332800
[TBL] [Abstract][Full Text] [Related]
20. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
Jukić T; Stanicić J; Petric V; Kusić Z
Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]